ATE85345T1 - Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. - Google Patents

Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Info

Publication number: ATE85345T1
Authority: AT; Austria
Prior art keywords: fragment; anf; cdd; arg; ser
Prior art date: 1987-03-02

Application number

AT88901838T

Other languages

English (en)

Inventor

Wolf-Georg Forssmann

Jeanette M Alt

Gerhard Becker

Franz Herbst

Original Assignee

Forssmann Wolf Georg

Bissendorf Peptide Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-03-02

Filing date

1988-02-27

Publication date

1993-02-15

1987-03-02 Priority claimed from DE19873706731 external-priority patent/DE3706731A1/de

1987-05-22 Priority claimed from DE19873717329 external-priority patent/DE3717329A1/de

1988-02-27 Application filed by Forssmann Wolf Georg, Bissendorf Peptide Gmbh filed Critical Forssmann Wolf Georg

1993-02-15 Application granted granted Critical

1993-02-15 Publication of ATE85345T1 publication Critical patent/ATE85345T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Diabetes (AREA)
Zoology (AREA)
Ophthalmology & Optometry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

AT88901838T 1987-03-02 1988-02-27 Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. ATE85345T1 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE19873706731 DE3706731A1 (de)	1987-03-02	1987-03-02	Neues cardiodilatinfragment und verfahren zur gewinnung von cardiodilatinfragmenten
DE19873717329 DE3717329A1 (de)	1987-05-22	1987-05-22	Neues cardiodilatinfragment, verfahren zu seiner gewinnung und seine verwendung
DE3741641		1987-12-09
PCT/EP1988/000144 WO1988006596A1 (en)	1987-03-02	1988-02-27	New cardiodilatin fragment, process for preparing same and use thereof
EP88901838A EP0349545B1 (de)	1987-03-02	1988-02-27	Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung

Publications (1)

Publication Number	Publication Date
ATE85345T1 true ATE85345T1 (de)	1993-02-15

Family

ID=27195544

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88901838T ATE85345T1 (de)	1987-03-02	1988-02-27	Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Country Status (7)

Country	Link
EP (1)	EP0349545B1 (de)
JP (1)	JP2819467B2 (de)
AT (1)	ATE85345T1 (de)
AU (1)	AU614738B2 (de)
DE (1)	DE3878231T2 (de)
DK (1)	DK174112B1 (de)
WO (1)	WO1988006596A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5262521A (en) *	1991-06-07	1993-11-16	Sri International	Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
DE4216133A1 (de) *	1992-05-15	1993-11-18	Bissendorf Peptide Gmbh	Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen
US6525022B1 (en)	1993-11-12	2003-02-25	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5846932A (en) *	1993-11-12	1998-12-08	Genentech, Inc.	Receptor specific atrial natriuretic peptides
US5665704A (en) *	1993-11-12	1997-09-09	Genentech, Inc.	Receptor specific atrial natriuretic peptides
EP0763061B1 (de) *	1994-06-02	2002-10-30	Forssmann, Wolf-Georg, Prof. Dr. med.	Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung
DE19535445A1 (de) *	1995-09-23	1997-03-27	Boehringer Mannheim Gmbh	Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine
US6136564A (en) *	1995-11-16	2000-10-24	Roche Diagnostics Gmbh	Process for the production of peptides by way of streptavidin fusion proteins
DE19951471A1 (de)	1999-10-26	2001-05-03	Forssmann Wolf Georg	Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
DE10116552A1 (de)	2001-04-03	2002-10-10	Abc Armbruster Biochemicals	Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
US7732406B2 (en)	2005-04-07	2010-06-08	Cardiopep Pharma Gmbh	Use of natriuretic peptide for treating heart failure
US8580746B2 (en)	2006-03-30	2013-11-12	Palatin Technologies, Inc.	Amide linkage cyclic natriuretic peptide constructs
WO2007115175A2 (en)	2006-03-30	2007-10-11	Palatin Technologies, Inc.	Cyclic natriuretic peptide constructs
JP2009532385A (ja)	2006-03-30	2009-09-10	パラティン・テクノロジーズ・インコーポレーテッド	線状ナトリウム利尿ペプチド構築物
EP2185183B1 (de) *	2007-09-11	2016-03-16	Cardiopep Pharma GmbH	Verwendung von natriuretischen peptiden zur behandlung von angioödemen
EP2631247A1 (de)	2012-02-22	2013-08-28	Immundiagnostik AG	Mittel und Verfahren zum Messen des Parathyroid-Hormons bei unter oxidativem Stress leidenden Patienten
ES2689193T3 (es)	2013-03-08	2018-11-08	Immundiagnostik Ag	La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis
US20200371118A1 (en)	2018-01-17	2020-11-26	Immundiagnostik Ag	Biomarker predicting coronary artery diseases
FR3099056B1 (fr) *	2019-07-26	2022-08-12	Univ Rouen Normandie	Utilisation de l’ANP pour détruire les biofilms bactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0180615B1 (de) *	1984-04-19	1995-04-05	Scios Nova Inc.	Atrielle natriumuretische/gefässerweiterende polypeptide
DE3443257A1 (de) *	1984-11-28	1986-05-28	Bissendorf Peptide GmbH, 3002 Wedemark	Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)

1988
- 1988-02-27 EP EP88901838A patent/EP0349545B1/de not_active Expired - Lifetime
- 1988-02-27 WO PCT/EP1988/000144 patent/WO1988006596A1/en active IP Right Grant
- 1988-02-27 DE DE8888901838T patent/DE3878231T2/de not_active Expired - Lifetime
- 1988-02-27 AT AT88901838T patent/ATE85345T1/de not_active IP Right Cessation
- 1988-02-27 AU AU13481/88A patent/AU614738B2/en not_active Expired
- 1988-02-27 JP JP63502001A patent/JP2819467B2/ja not_active Expired - Lifetime
- 1988-11-02 DK DK198806108A patent/DK174112B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0349545B1 (de)	1993-02-03
JPH02502636A (ja)	1990-08-23
AU614738B2 (en)	1991-09-12
DK174112B1 (da)	2002-06-24
WO1988006596A1 (en)	1988-09-07
DK610888A (da)	1988-11-02
JP2819467B2 (ja)	1998-10-30
AU1348188A (en)	1988-09-26
DK610888D0 (da)	1988-11-02
DE3878231D1 (de)	1993-03-18
DE3878231T2 (de)	1993-05-27
EP0349545A1 (de)	1990-01-10

Publication	Publication Date	Title
ATE85345T1 (de)	1993-02-15	Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
PT93910A (pt)	1991-01-08	Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
TR199802789T2 (xx)	1999-03-22	Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
GEP20033002B (en)	2003-06-25	Osteoprotegerin Binding Protein and Receptors
ATE75483T1 (de)	1992-05-15	Oligonukleotides heilmittel und dessen herstellungsverfahren.
ATE32728T1 (de)	1988-03-15	Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
HUT58813A (en)	1992-03-30	Process for producing tissue-plasminogen activator derivative
ATA309588A (de)	1997-04-15	Neue kristallform von ciclosporin, verfahren zu ihrer herstellung, diese kristallform enthaltende pharmazeutische zusammensetzung und verwendung dieser kristallform
TW261615B (de)	1995-11-01
AU617989B2 (en)	1991-12-12	Variants of hirudin, their use and their preparation
DK482185A (da)	1986-04-23	Peptider, deres fremstilling og anvendelse som laegemidler
KR880011200A (ko)	1988-10-27	텐다미스탵 유도체
AR018532A1 (es)	2001-11-28	Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas
BG101846A (en)	1998-07-31	HUMAN DNase I VARIANTS
PT88913A (pt)	1988-12-01	Processo para a preparacao da proteina pp4-x anticoagulante
ATE6639T1 (de)	1984-03-15	Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat.
SE9402332D0 (sv)	1994-07-01	Igf-1
DK0580782T3 (da)	1998-05-04	Anti-HIV-protein, TAP 29, fra Trichosanthes, DNA, som koder derfor, og terapeutiske anvendelser deraf
BG101847A (en)	1998-07-31	Human dnase i variants
KR850002278A (ko)	1985-05-10	조환디엔에이 기술을 이용한 펩타이드의 제조방법
ATE55411T1 (de)	1990-08-15	Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen.
KR910016339A (ko)	1991-11-05	Pp4-델타, 이의 제조방법 및 용도

Legal Events

Date	Code	Title	Description
1993-08-15	UEP	Publication of translation of european patent specification
2003-11-15	REN	Ceased due to non-payment of the annual fee